Escalation to Weekly Adalimumab for the Treatment of Ocular Inflammation.
Saved in:
| Title: | Escalation to Weekly Adalimumab for the Treatment of Ocular Inflammation. |
|---|---|
| Authors: | Liberman P; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Departamento de Oftalmología, Facultad de Medicina, Pontificia Universidad Católica De Chile, Santiago, Chile., Berkenstock MK; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Burkholder BM; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Chaon BC; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Thorne JE; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Center for Clinical Trials and Data Synthesis, Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA. |
| Source: | Ocular immunology and inflammation [Ocul Immunol Inflamm] 2021 Nov 17; Vol. 29 (7-8), pp. 1564-1568. Date of Electronic Publication: 2020 May 14. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-5078 (Electronic) Linking ISSN: 09273948 NLM ISO Abbreviation: Ocul Immunol Inflamm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
